Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

15.77
-0.7000-4.25%
Volume:4.14M
Turnover:64.95M
Market Cap:2.43B
PE:-40.21
High:17.98
Open:17.82
Low:15.07
Close:16.47
52wk High:20.76
52wk Low:6.26
Shares:153.78M
Float Shares:117.37M
Volume Ratio:1.91
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3922
EPS(LYR):-0.3922
ROE:-27.82%
ROA:-6.79%
PB:11.08
PE(LYR):-40.21

Loading ...

Adaptive Biotechnologies (ADPT) Q4 Loss Narrows Yet Premium Valuation Tests Bullish Narratives

Simply Wall St.
·
Feb 07

Adaptive Biotechnologies CFO Kyle Piskel Reports Disposal of Common Shares

Reuters
·
Feb 07

Stock Track | Adaptive Biotechnologies Plummets 6.31% Intraday Following Analyst Insights

Stock Track
·
Feb 07

Stock Track | Adaptive Biotechnologies Soars 8.20% Intraday on Analyst Price Target Upgrades

Stock Track
·
Feb 06

Analysts Are Bullish on These Healthcare Stocks: Adaptive Biotechnologies (ADPT), Opus Genetics (IRD)

TIPRANKS
·
Feb 06

Adaptive Biotechnologies price target raised to $22 from $21 at BTIG

TIPRANKS
·
Feb 06

Adaptive Biotechnologies price target raised to $21 from $20 at JPMorgan

TIPRANKS
·
Feb 06

Adaptive Biotechnologies Is Maintained at Buy by BTIG

Dow Jones
·
Feb 06

Earnings Flash (ADPT) Adaptive Biotechnologies Posts Q4 Loss $0.09, vs. FactSet Est of $0.19 Loss

MT Newswires Live
·
Feb 06

Stock Track | Adaptive Biotechnologies Soars 6.25% After-Hours on Strong Q4 Results and Positive Guidance

Stock Track
·
Feb 06

Adaptive Biotechnologies Q4 EPS $(0.09) Beats $(0.18) Estimate, Sales $71.681M Beat $59.391M Estimate

Benzinga
·
Feb 06

Adaptive meldet für das Gesamtjahr einen Nettoverlust von 159,49 Mio. USD, ein Anstieg um 169 Prozent

Reuters
·
Feb 06

BRIEF-Adaptive Biotechnologies Q4 EPS USD -0.09

Reuters
·
Feb 06

Adaptive Biotechnologies: Expects FY Revenue for Mrd Business to Be Between $255 Million - $265 Million

THOMSON REUTERS
·
Feb 06

Adaptive Biotechnologies: Expect FY Operating Expenses, Including Cost of Revenue, to Be Between $350 Mln - $360 Mln

THOMSON REUTERS
·
Feb 06

Stock Track | Adaptive Biotechnologies Plunges 10.40% in Pre-Market on Earnings Anticipation

Stock Track
·
Feb 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 05

Adaptive Biotechnologies CEO Chad M. Robins Reports Sale of Common Shares

Reuters
·
Feb 05

Earning Preview: Adaptive Biotechnologies Corp’s revenue is expected to increase by 29.02%, and institutional views are cautiously optimistic

Earnings Agent
·
Jan 29

Adaptive Biotechnologies to Participate in BTIG and TD Cowen Investor Conferences

Reuters
·
Jan 28